avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxa3 | mm10_v2_chr7_-_19023538_19023546 | 0.20 | 2.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_127898515 Show fit | 14.52 |
ENSMUST00000047134.7
|
4short chain dehydrogenase/reductase family 9C, member 7 |
|
chr17_-_12675833 Show fit | 11.23 |
ENSMUST00000024596.8
|
solute carrier family 22 (organic cation transporter), member 1 |
|
chr17_-_31144271 Show fit | 10.30 |
ENSMUST00000024826.7
|
trefoil factor 2 (spasmolytic protein 1) |
|
chr16_+_91269759 Show fit | 6.71 |
ENSMUST00000056882.5
|
oligodendrocyte transcription factor 1 |
|
chr19_+_20601958 Show fit | 6.59 |
ENSMUST00000087638.3
|
aldehyde dehydrogenase family 1, subfamily A1 |
|
chr4_-_60421933 Show fit | 6.57 |
ENSMUST00000107506.2
ENSMUST00000122381.1 ENSMUST00000118759.1 ENSMUST00000122177.1 |
major urinary protein 9 |
|
chr1_+_130865669 Show fit | 6.27 |
ENSMUST00000038829.5
|
Fas apoptotic inhibitory molecule 3 |
|
chr3_-_113258837 Show fit | 6.26 |
ENSMUST00000098673.3
|
amylase 2a5 |
|
chrX_-_108664891 Show fit | 5.94 |
ENSMUST00000178160.1
|
predicted gene 379 |
|
chr3_+_107230608 Show fit | 5.89 |
ENSMUST00000179399.1
|
RIKEN cDNA A630076J17 gene |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 16.6 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.0 | 12.6 | GO:0055114 | oxidation-reduction process(GO:0055114) |
2.8 | 11.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.5 | 10.3 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 10.0 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
2.4 | 9.8 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.9 | 6.6 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 6.5 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.4 | 5.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.6 | 5.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 22.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 18.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 18.0 | GO:0005730 | nucleolus(GO:0005730) |
1.2 | 9.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 8.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 6.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.8 | 5.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.9 | 4.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.5 | 4.2 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 4.1 | GO:0001650 | fibrillar center(GO:0001650) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 14.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
3.8 | 11.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
3.7 | 11.2 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.8 | 10.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
3.3 | 9.8 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.9 | 9.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 8.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 7.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.9 | 6.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 5.3 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 10.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 5.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 5.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 4.5 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 3.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 2.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 2.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 2.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 2.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 2.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 29.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
2.0 | 12.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 11.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 9.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 7.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 5.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 5.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 4.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 4.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 4.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |